Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

GENE TOX WORLDWIDE LLC

NPI: 1134588817 · LYNDHURST, NJ 07071 · Clinical Medical Laboratory · NPI assigned 02/23/2016

$37.26M
Total Medicaid Paid
604,561
Total Claims
330,602
Beneficiaries
76
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGENTILE, CHARLES (CEO)
NPI Enumeration Date02/23/2016

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 17,497 $1.81M
2019 24,279 $2.82M
2020 55,844 $5.32M
2021 86,663 $5.39M
2022 146,061 $6.94M
2023 142,332 $7.66M
2024 131,885 $7.31M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 322,165 138,400 $14.29M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 124,185 91,361 $11.16M
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 31,454 15,961 $3.50M
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 37,577 25,916 $3.29M
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 19,267 12,080 $2.54M
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 26,887 15,317 $1.85M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 16,683 9,256 $375K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 6,520 2,862 $114K
86803 1,242 1,224 $22K
80053 Comprehensive metabolic panel 2,016 1,987 $20K
87340 1,179 1,162 $13K
86706 991 980 $11K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 308 306 $11K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 297 295 $10K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2,001 1,958 $8K
86696 304 301 $6K
86695 303 300 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 327 323 $4K
86705 486 476 $4K
86708 304 301 $4K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 109 107 $3K
84443 Thyroid stimulating hormone (TSH) 150 148 $3K
87522 Neg quan hep c or qual rna 113 111 $2K
86593 716 710 $2K
86735 109 107 $2K
82607 111 109 $2K
84134 102 100 $2K
83735 311 308 $1K
84480 83 82 $1K
84439 118 117 $1K
82746 110 109 $1K
86765 109 107 $1K
81003 671 658 $957.00
84481 65 65 $946.45
84100 310 307 $924.00
80061 Lipid panel 62 61 $922.68
86762 135 133 $754.00
81015 749 744 $713.00
86592 1,081 1,069 $533.50
83718 64 63 $488.00
84478 60 60 $407.15
84702 28 28 $318.92
83036 Hemoglobin; glycosylated (A1C) 43 42 $283.80
84479 50 50 $276.00
84436 48 48 $264.00
86780 19 19 $201.21
82248 28 28 $126.00
82977 24 24 $115.20
81001 13 12 $10.80
80323 160 154 $10.70
82465 60 60 $9.00
80356 247 236 $8.80
80354 313 300 $8.80
80348 315 302 $8.80
80365 315 302 $8.80
80363 249 241 $8.80
80346 307 294 $7.98
80358 312 299 $7.38
80353 208 199 $6.84
83992 166 160 $6.64
80361 315 302 $5.72
80355 196 189 $5.72
80359 189 180 $5.72
80349 200 191 $5.72
80357 162 156 $5.72
80366 195 188 $5.66
80373 101 100 $0.00
80337 12 12 $0.00
80370 43 43 $0.00
80372 94 93 $0.00
80321 50 50 $0.00
80364 31 29 $0.00
80360 59 59 $0.00
80375 25 25 $0.00
80324 101 97 $0.00
80368 49 49 $0.00